Abbot Financial Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.15M | Buy |
13,127
+1,284
| +11% | +$112K | 0.53% | 54 |
|
|
2025
Q1 | $809K | Buy |
11,843
+40
| +0.3% | +$2.73K | 0.42% | 67 |
|
|
2024
Q4 | $918K | Sell |
11,803
-20
| -0.2% | -$1.56K | 0.46% | 58 |
|
|
2024
Q3 | $793K | Buy |
11,823
+4,374
| +59% | +$293K | 0.4% | 68 |
|
|
2024
Q2 | $845K | Buy |
7,449
+455
| +7% | +$51.6K | 0.45% | 59 |
|
|
2024
Q1 | $970K | Buy |
6,994
+337
| +5% | +$46.7K | 0.54% | 51 |
|
|
2023
Q4 | $826K | Buy |
6,657
+1,560
| +31% | +$194K | 0.5% | 60 |
|
|
2023
Q3 | $476K | Buy |
5,097
+1,177
| +30% | +$110K | 0.32% | 81 |
|
|
2023
Q2 | $504K | Sell |
3,920
-193
| -5% | -$24.8K | 0.32% | 79 |
|
|
2023
Q1 | $478K | Hold |
4,113
| – | – | 0.32% | 79 |
|
|
2022
Q4 | $466K | Buy |
4,113
+25
| +0.6% | +$2.83K | 0.32% | 78 |
|
|
2022
Q3 | $329K | Hold |
4,088
| – | – | 0.23% | 89 |
|
|
2022
Q2 | $305K | Buy |
4,088
+396
| +11% | +$29.5K | 0.18% | 100 |
|
|
2022
Q1 | $472K | Buy |
3,692
+344
| +10% | +$44K | 0.23% | 90 |
|
|
2021
Q4 | $449K | Buy |
3,348
+52
| +2% | +$6.97K | 0.2% | 92 |
|
|
2021
Q3 | $451K | Sell |
3,296
-1,144
| -26% | -$157K | 0.21% | 92 |
|
|
2021
Q2 | $474K | Buy |
4,440
+288
| +7% | +$30.7K | 0.21% | 88 |
|
|
2021
Q1 | $373K | Buy |
4,152
+336
| +9% | +$30.2K | 0.17% | 94 |
|
|
2020
Q4 | $353K | Buy |
+3,816
| New | +$353K | 0.2% | 90 |
|